These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 26633560

  • 1. Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
    Amatu A, Somaschini A, Cerea G, Bosotti R, Valtorta E, Buonandi P, Marrapese G, Veronese S, Luo D, Hornby Z, Multani P, Murphy D, Shoemaker R, Lauricella C, Giannetta L, Maiolani M, Vanzulli A, Ardini E, Galvani A, Isacchi A, Sartore-Bianchi A, Siena S.
    Br J Cancer; 2015 Dec 22; 113(12):1730-4. PubMed ID: 26633560
    [Abstract] [Full Text] [Related]

  • 2. Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.
    Siravegna G, Sartore-Bianchi A, Mussolin B, Cassingena A, Amatu A, Novara L, Buscarino M, Corti G, Crisafulli G, Bartolini A, Tosi F, Erlander M, Di Nicolantonio F, Siena S, Bardelli A.
    Ann Oncol; 2017 Jun 01; 28(6):1302-1308. PubMed ID: 28368455
    [Abstract] [Full Text] [Related]

  • 3. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
    Lee J, Kim HC, Hong JY, Wang K, Kim SY, Jang J, Kim ST, Park JO, Lim HY, Kang WK, Park YS, Lee J, Lee WY, Park YA, Huh JW, Yun SH, Do IG, Kim SH, Balasubramanian S, Stephens PJ, Ross JS, Li GG, Hornby Z, Ali SM, Miller VA, Kim KM, Ou SH.
    Oncotarget; 2015 Sep 15; 6(27):24320-32. PubMed ID: 26172300
    [Abstract] [Full Text] [Related]

  • 4. Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.
    Rolfo C, Ruiz R, Giovannetti E, Gil-Bazo I, Russo A, Passiglia F, Giallombardo M, Peeters M, Raez L.
    Expert Opin Investig Drugs; 2015 Sep 15; 24(11):1493-500. PubMed ID: 26457764
    [Abstract] [Full Text] [Related]

  • 5. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
    Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG.
    Cancer Discov; 2017 Apr 15; 7(4):400-409. PubMed ID: 28183697
    [Abstract] [Full Text] [Related]

  • 6. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
    Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, Ballinari D, Ciomei M, Texido G, Degrassi A, Avanzi N, Amboldi N, Saccardo MB, Casero D, Orsini P, Bandiera T, Mologni L, Anderson D, Wei G, Harris J, Vernier JM, Li G, Felder E, Donati D, Isacchi A, Pesenti E, Magnaghi P, Galvani A.
    Mol Cancer Ther; 2016 Apr 15; 15(4):628-39. PubMed ID: 26939704
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.
    J Natl Cancer Inst; 2016 Jan 15; 108(1):. PubMed ID: 26563355
    [Abstract] [Full Text] [Related]

  • 8. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM, Farnham PJ.
    Mol Carcinog; 2000 Feb 15; 27(2):84-96. PubMed ID: 10657901
    [Abstract] [Full Text] [Related]

  • 9. Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia.
    Smith KM, Fagan PC, Pomari E, Germano G, Frasson C, Walsh C, Silverman I, Bonvini P, Li G.
    Mol Cancer Ther; 2018 Feb 15; 17(2):455-463. PubMed ID: 29237803
    [Abstract] [Full Text] [Related]

  • 10. Localization of the Chinese hamster CAD gene reveals homology between human chromosome 2p and Chinese hamster 7q.
    Bertoni L, Attolini C, Simi S, Giulotto E.
    Genomics; 1993 Jun 15; 16(3):779-81. PubMed ID: 8100805
    [Abstract] [Full Text] [Related]

  • 11. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish.
    Coxam B, Neyt C, Grassini DR, Le Guen L, Smith KA, Schulte-Merker S, Hogan BM.
    Dev Dyn; 2015 Jan 15; 244(1):1-9. PubMed ID: 25294789
    [Abstract] [Full Text] [Related]

  • 12. An unusual Alu repeat sequence within the CAD gene.
    Davidson JN, Khattar NH, Chen KC.
    J Mol Evol; 1991 Feb 15; 32(2):162-6. PubMed ID: 1672552
    [Abstract] [Full Text] [Related]

  • 13. Organization and nucleotide sequence of the 3' end of the human CAD gene.
    Davidson JN, Rao GN, Niswander L, Andreano C, Tamer C, Chen KC.
    DNA Cell Biol; 1990 Nov 15; 9(9):667-76. PubMed ID: 1979741
    [Abstract] [Full Text] [Related]

  • 14. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.
    Farago AF, Le LP, Zheng Z, Muzikansky A, Drilon A, Patel M, Bauer TM, Liu SV, Ou SH, Jackman D, Costa DB, Multani PS, Li GG, Hornby Z, Chow-Maneval E, Luo D, Lim JE, Iafrate AJ, Shaw AT.
    J Thorac Oncol; 2015 Dec 15; 10(12):1670-4. PubMed ID: 26565381
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene.
    Farnham PJ, Kollmar R.
    Cell Growth Differ; 1990 Apr 15; 1(4):179-89. PubMed ID: 1982061
    [Abstract] [Full Text] [Related]

  • 16. Entrectinib: First Global Approval.
    Al-Salama ZT, Keam SJ.
    Drugs; 2019 Sep 15; 79(13):1477-1483. PubMed ID: 31372957
    [Abstract] [Full Text] [Related]

  • 17. The evolutionary history of the first three enzymes in pyrimidine biosynthesis.
    Davidson JN, Chen KC, Jamison RS, Musmanno LA, Kern CB.
    Bioessays; 1993 Mar 15; 15(3):157-64. PubMed ID: 8098212
    [Abstract] [Full Text] [Related]

  • 18. Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases.
    Salifu EY, Issahaku AR, Agoni C, Ibrahim MAA, Manimbulu N, Soliman MES.
    Cell Biochem Biophys; 2022 Mar 15; 80(1):11-21. PubMed ID: 35040089
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
    Chen KF, Lai YY, Sun HS, Tsai SJ.
    Nucleic Acids Res; 2005 Mar 15; 33(16):5190-8. PubMed ID: 16155188
    [Abstract] [Full Text] [Related]

  • 20. Revision in sequence of CAD aspartate transcarbamylase domain of Drosophila.
    Davidson JN, Kern CB.
    J Mol Biol; 1994 Oct 21; 243(2):364-6. PubMed ID: 7932764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.